- Home
- Articles
- latamerica
- drug distribution
Drug Distribution Articles & Analysis
26 articles found
Precise and safe delivery of drugs to target sites has always been an important task for researchers in modern medicine. ...
This method allows the creation of films with multiple layers, enabling the combination of various drugs and excipients tailored to specific research needs. By adjusting the composition, layer thickness, and distribution of APIs, researchers can enhance the functionality of drug delivery systems. Additionally, 3D printing can address issues such ...
In the realm of pharmaceutical research and development, ADME testing services play a pivotal role in evaluating the pharmacokinetics of drug candidates. ADME stands for Absorption, Distribution, Metabolism, and Excretion, which are critical processes that determine the fate of a drug within the body. ...
When studied in living organisms, this relationship is referred to as in vivo PK/PD, a discipline that provides invaluable insights into drug behavior within a biological context. Pharmacokinetics: The Journey of a Drug The pharmacokinetic profile of a drug describes its absorption, distribution, metabolism, and excretion (ADME) ...
Pharmacokinetics (PK) and Toxicokinetics (TK) studies are virtues of a broader scientific discipline called pharmacology. PK focuses on the journey of drugs through the body, revealing the trajectory of drug absorption, distribution, metabolism, and excretion, collectively known as ADMET. ...
Pharmacokinetic characteristics are composed of and determined by drug absorption, distribution, metabolism and excretion. The structure, physiological properties and pharmacokinetic characteristics of monoclonal antibodies are different from those of traditional small molecule drugs. ...
Antibody-drug conjugates (ADCs) represent a groundbreaking class of therapeutics that combine the specificity of monoclonal antibodies (mAbs) with the potent cytotoxic effects of small-molecule drugs. ...
Drug-to-antibody ratio (DAR) analysis With the dissociation of small-molecule drugs or the different DAR values of ADC in the body, the ADC clearance rate is different, and the DAR value distribution is also changing. ...
In order to more effectively deliver chemotherapy drugs, Small Molecule Drug Conjugates (SMDC), Antibody Drug Conjugates (ADC), and Degradation Antibody Conjugates (DAC) have been successively explored and developed, enhancing the therapeutic index while providing selective delivery. ...
One critical element in the drug development process is drug metabolism and pharmacokinetics (DMPK), which refers to how a drug is absorbed, distributed, metabolized, and excreted (ADME) from the body. In vitro DMPK services, along with absorption, distribution, metabolism, excretion, and toxicity (ADMET) ...
Conventional liposomes As a drug delivery system, traditional liposomes can change the pharmacokinetic properties and tissue distribution of tumor drugs, enhance the target aggregation concentration of drugs, and enhance drug efficacy. However, traditional liposomes still have shortcomings such as unsatisfactory ...
Antibody drug conjugates (ADCs) are a new class of biopharmaceuticals that use monoclonal antibodies to target tumor cells to deliver potent cytotoxic drugs. ...
One critical element in the drug development process is drug metabolism and pharmacokinetics (DMPK), which refers to how a drug is absorbed, distributed, metabolized, and excreted (ADME) from the body. In vitro DMPK services, along with absorption, distribution, metabolism, excretion, and toxicity (ADMET) ...
It is a crucial parameter that directly impacts the therapeutic efficacy of the drug delivery system. Particle size distribution is another vital parameter that determines the physical characteristics of the microcapsules. A narrow particle size distribution ensures uniformity, which is essential for consistent drug release. ...
Nano-vesicles, also known as liposomes, have emerged as promising drug delivery systems due to their unique structure and properties. These tiny spherical lipid bilayers can encapsulate various therapeutic agents, including protein drugs. ...
This article aims to provide an overview of different bioconjugation strategies employed for various drug classes, highlighting their advantages, challenges, and potential applications Bioconjugation involves the covalent linkage of drugs or drug carriers to biological macromolecules, thereby enhancing their stability, solubility, and ...
Firstly, they provide information on drug absorption, distribution, metabolism, and elimination, which are crucial for determining appropriate dosages and treatment regimens in humans. ...
Average drug-to-antibody ratio (DAR) and drug load distribution are two vital properties of antibody drug conjugates (ADCs). ...
Drug-to-antibody ratio (DAR, drug-to-antibody ratio) The number of cytotoxic drugs connected to each antibody is the drug-to-antibody ratio (DAR). When the DAR increases, the drug metabolism rate of ADC drugs increases, the half-life decreases, and the systemic toxicity increases. ...
CYP450 and Biosynthesis CYP450 involved in drug metabolism mainly includes seven important subtypes of CYP1, CYP2, and CPY3 families, especially CPY3A4. CYP3 family accounts for 28.8% of the total intrahepatic CYP450, which is an important enzyme involved in the first-pass effect of oral drugs. Many opioid analgesics can be metabolized by CYP3A4, and ...